文献速递冠心病

ICare-ACS:疑似急性冠脉综合征国家临床路径的跨系统实施研究

ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
PubMed 文献 · Circulation · 2017-11-14

路径包括结构化风险分层、3小时内心电图与系列肌钙蛋白检测及加速诊断方案。结果显示6小时出院率由8.3%升至18.4%,出院 odds 比2.4(95%CI 2.3-2.6),无ACS患者中位住院时间缩短2.9小时,6小时内出院者30天主要不良心脏事件率无变化。

要点

  • 国家临床路径实施后6小时出院率由8.3%升至18.4%,出院 odds 比2.4(95%CI 2.3-2.6)。
  • 无ACS患者中位住院时间缩短2.9小时(95%CI 2.4-3.4)。
  • 6小时内出院者30天主要不良心脏事件率无变化(0.52% vs 0.44%,P=0.96)。

核心结论

  • 实施疑似ACS临床路径可缩短住院时间并提高6小时内安全出院比例。
  • 6小时内出院患者30天主要不良心脏事件率无变化,正确遵循路径时无不良事件发生。

研究设计与样本

  • 多中心务实性阶梯式前后对照试验,在新西兰7家急症医院开展。
  • 临床路径包括纸质或电子路径文档、结构化风险分层、到达3小时内心电图与系列肌钙蛋白检测时间点,以及加速诊断方案。
  • 实施监测超过4个月,与之前6个月常规护理比较。

主要发现

  • 总体平均6小时出院率从8.3%(范围2.7%-37.7%)升至18.4%(范围6.8%-43.8%)。
  • 临床路径实施后6小时内出院 odds 比2.4(95%CI 2.3-2.6)。
  • 无ACS患者中位住院时间缩短2.9小时(95%CI 2.4-3.4)。
  • 6小时内出院者30天主要不良心脏事件率0.52% vs 0.44%(P=0.96)。
  • 正确遵循临床路径时,6小时内出院患者无不良事件发生。

关键数值与推荐

  • 临床路径要求到达3小时内完成心电图和系列肌钙蛋白检测。
  • 采用结构化风险分层并结合心电图与肌钙蛋白结果,按加速诊断方案评估。

临床怎么用

  • 对疑似ACS患者可采用包含结构化风险分层和3小时内系列肌钙蛋白检测的临床路径。
  • 路径有助于识别可安全在6小时内出院的低危患者,缩短无ACS患者住院时间。
  • 实施路径时需确保正确遵循,以维持6小时内出院患者的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Efforts to safely reduce length of stay for emergency department patients with symptoms suggestive of acute coronary syndrome (ACS) have had mixed success. Few system-wide efforts affecting multiple hospital emergency departments have ever been evaluated. We evaluated the effectiveness of a nationwide implementation of clinical pathways for potential ACS in disparate hospitals. METHODS: This was a multicenter pragmatic stepped-wedge before-and-after trial in 7 New Zealand acute care hospitals with 31 332 patients investigated for suspected ACS with serial troponin measurements. The implementation was a clinical pathway for the assessment of patients with suspected ACS that included a clinical pathway document in paper or electronic format, structured risk stratification, specified time points for electrocardiographic and serial troponin testing within 3 hours of arrival, and directions for combining risk stratification and electrocardiographic and troponin testing in an accelerated diagnostic protocol. Implementation was monitored for >4 months and compared with usual care over the preceding 6 months. The main outcome measure was the odds of discharge within 6 hours of presentation RESULTS: There were 11 529 participants in the preimplementation phase (range, 284-3465) and 19 803 in the postimplementation phase (range, 395-5039). Overall, the mean 6-hour discharge rate increased from 8.3% (range, 2.7%-37.7%) to 18.4% (6.8%-43.8%). The odds of being discharged within 6 hours increased after clinical pathway implementation. The odds ratio was 2.4 (95% confidence interval, 2.3-2.6). In patients without ACS, the median length of hospital stays decreased by 2.9 hours (95% confidence interval, 2.4-3.4). For patients discharged within 6 hours, there was no change in 30-day major adverse cardiac event rates (0.52% versus 0.44%; P=0.96). In these patients, no adverse event occurred when clinical pathways were correctly followed. CONCLUSIONS: Implementation of clinical pathways for suspected ACS reduced the length of stay and increased the proportions of patients safely discharged within 6 hours. CLINICAL TRIAL REGISTRATION: URL: https://www.anzctr.org.au/ (Australian and New Zealand Clinical Trials Registry). Unique identifier: ACTRN12617000381381.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Than MP, Pickering JW, Dryden JM, et al. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2017. PMID: 29138293. doi:10.1161/CIRCULATIONAHA.117.031984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。